Kyowa Hakko Kirin at a Glance
Who we are
Kyowa Hakko Kirin is a R&D-based pharmaceutical company with special strengths in biotechnology.
The Kyowa Hakko Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.
Our Business Fields
- Kyowa Hakko Kirin/ Ethical Drugs
- Kyowa Hakko Bio/ Bio-Chemicals
- Kyowa Medex/ Diagnostics
- FUJIFILM KYOWA KIRIN BIOLOGICS/ Biosimilars
Our Business Strategy
Kyowa Hakko Kirin will further strengthen competitiveness in Japan through our category-based strategy. Category-based strategy applies to following four disease area:
- Central Nervous System
FY2016-2020 Mid-term Business Plan(1,694KB)
Kyowa Hakko Kirin’s products are all produced using cutting-edge manufacturing technology and equipment and under our strict quality assurance system and in full compliance with global standards.
Kyowa Hakko Kirin is a pharmaceutical company, formed from a combination of the depth of experience and strong business record of Kyowa Hakko and Kirin Pharma.
Kyowa Hakko Kirin is working to discover and create new ways to improve wellness and treat disease with a special focus on:
- Immunology and allergy
Kyowa Hakko Kirin also undertakes drug discovery and try new approaches especially on:
- Therapeutic antibodies
- Small molecule drugs
- Nucleic acid drugs
Kyowa Hakko Kirin Investors Relations
Current or prospective investors can find information on stock and Kyowa Hakko Kirin, corporate governance, financials, links to events and presentations.